Editorial
Published on 05 May 2022
Editorial: Epigenetic Regulation and Tumor Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.893157
- 2,327 views
- 6 citations
Type at least 3 characters
1,334 articles
Articles
Editorial
Published on 04 May 2022
Editorial: Immune-Related Adverse Events for Patients With Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.898576
- 1,444 views
Original Research
Published on 04 May 2022
Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.869393
- 5,212 views
- 6 citations
Original Research
Published on 29 Apr 2022
Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.864533
- 3,369 views
- 25 citations
Original Research
Published on 29 Apr 2022
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.873293
- 4,752 views
- 10 citations
Review
Published on 28 Apr 2022
The Immune Microenvironment in Gastric Cancer: Prognostic Prediction
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.836389
- 4,231 views
- 13 citations
Original Research
Published on 28 Apr 2022
From Fitting the Average to Fitting the Individual: A Cautionary Tale for Mathematical Modelers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.793908
- 1,958 views
- 13 citations
Mini Review
Published on 28 Apr 2022
Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.891187
- 7,141 views
- 14 citations
Original Research
Published on 27 Apr 2022
Construction of a Prognostic Model for Hypoxia-Related LncRNAs and Prediction of the Immune Landscape in the Digestive System Pan-Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.812786
- 3,069 views
- 4 citations
Review
Published on 27 Apr 2022
Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.864159
- 6,683 views
- 13 citations
Original Research
Published on 22 Apr 2022
Adiponectin Deficiency Enhances Anti-Tumor Immunity of CD8+ T Cells in Rhabdomyosarcoma Through Inhibiting STAT3 Activation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.847088
- 2,079 views
- 5 citations
Original Research
Published on 22 Apr 2022
DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.882714
- 2,744 views
- 8 citations
Original Research
Published on 22 Apr 2022
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.818437
- 5,832 views
- 10 citations
Original Research
Published on 22 Apr 2022
Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.870528
- 4,792 views
- 11 citations
Original Research
Published on 22 Apr 2022
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.871390
- 5,196 views
- 19 citations
Original Research
Published on 21 Apr 2022
Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer Patients
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.837525
- 5,020 views
- 14 citations